Today: 9 April 2026
Dow rebounds toward 50,000 as tech snaps back; bitcoin and gold claw higher while Amazon capex rattles AI bets

Dow rebounds toward 50,000 as tech snaps back; bitcoin and gold claw higher while Amazon capex rattles AI bets

NEW YORK, Feb 6, 2026, 14:35 (EST)

Stocks snapped back on Friday, reversing course after three straight sessions of selling that dragged down big tech and other risk plays. By 12:10 p.m. ET, the Dow was up 989.72 points, or 2.02%, sitting at 49,898.44. The S&P 500 added 1.56%, while the Nasdaq jumped 1.69%, according to Reuters data. “The market looks like it was getting a bit overdone to the downside,” said Robert Pavlik, senior portfolio manager at Dakota Wealth. Reuters

This shift is shaking up the AI trade, as investors get choosier about who stands to gain—or lose—going forward. Software stocks have taken the brunt of it this week: ServiceNow has dropped 12%, Salesforce is down 9%. Hardware, the “picks ’n shovels” of AI, is proving more resilient, Reuters said. “Investors are differentiating between who enables AI and who may be disrupted by it,” said Charu Chanana, chief investment strategist at Saxo. Reuters

Company budgets are reflecting the divide. Alphabet, Microsoft, Amazon, and Meta together are on track to shell out more than $630 billion this year, Reuters reports, most of it aimed at AI. Investors are watching to see if those dollars actually pay off. Amazon alone has lined up $200 billion in spending, with Alphabet just behind at up to $185 billion, and Meta anticipating as much as $135 billion. Reuters

Chip stocks snapped higher Friday—Nvidia surged roughly 7%, Broadcom tacked on over 5%, and AMD jumped close to 7.5% by late morning. The Philadelphia SE Semiconductor index tracked a 4.6% pop, Reuters noted. Amazon’s downturn still cast a shadow over AI spending, but semis shrugged it off for now. “We’re going to continue to see these ebbs and flows,” said Ben Falcone, managing director at Kayne Anderson Rudnick. Reuters

Amazon’s latest figures have intensified the conversation. According to Reuters, the company expects its capital expenditures to hit $200 billion in 2026, a significant jump from $131 billion forecast for 2025. Chief executive Andy Jassy tried to put a positive spin on the spending spree: “We are being incredibly scrappy.” D.A. Davidson analyst Gil Luria didn’t mince words: “Amazon has to invest at these levels just to stay in the race.” Reuters

Crypto snapped back after a sharp selloff the previous day. On Thursday, Bitcoin dropped as low as $63,295.74—its softest showing since October 2024—and was last down 12.6% in that session, Reuters noted. Around $1 billion in bitcoin positions got wiped out over the course of 24 hours, CoinGlass data showed. “It’s clear the crypto market is now in full capitulation mode,” said Nic Puckrin, co-founder of Coin Bureau. Reuters

U.S. consumer data showed a headline gain, but the details were mixed. The University of Michigan’s Consumer Sentiment Index edged up to 57.3 in early February from 56.4 a month earlier, according to Reuters, with most of the lift coming from households holding the most stocks. “We may have seen the trough in consumer sentiment,” said Oren Klachkin, financial markets economist at Nationwide, though he isn’t betting on a sharp bounce. Reuters

Oil traders watched developments in Oman, with Iran and the U.S. meeting for nuclear talks that Tehran described as a “good start,” according to Reuters. Iran’s foreign minister signaled more discussions ahead, though Washington imposed new sanctions linked to Iranian petroleum trade—a signal that both diplomatic overtures and pressure tactics are in play. Reuters

There’s a catch to this rally. Should the AI capex surge fall short on earnings, or if rates don’t budge and funding pressures worsen, the “buy the dip” crowd can snap right back to selling. Crypto’s still on edge, and the Middle East can swing on a headline. That makes Friday’s rebound feel more like a pause than a conclusion.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Analog Devices stock sits out chip surge as AI-spending nerves keep traders jumpy
Previous Story

Analog Devices stock sits out chip surge as AI-spending nerves keep traders jumpy

SMCI stock price rebounds nearly 10% as Super Micro swings again after Thursday selloff
Next Story

SMCI stock price rebounds nearly 10% as Super Micro swings again after Thursday selloff

Go toTop